Published in
Elsevier, Year Book of Medicine, (2012), p. 40
DOI: 10.1016/j.ymed.2012.09.014
Lippincott, Williams & Wilkins, JCR: Journal of Clinical Rheumatology, 4(17), p. 169-172, 2011
DOI: 10.1097/rhu.0b013e31821bfc48
Links
Tools
Rheumatic complaints in women taking aromatase inhibitors for treatment of hormone-dependent breast cancer
Journal article published in 2011 by
Raffaele Scarpa,
Mariangela Atteno,
Rosario Peluso,
Luisa Costa 
,
Stefania Padula,
Dario Di Minno,
Francesco Caso,
Salvatore Iervolino,
Maria Vitiello,
Antonio Del Puente,
R. S. Panush
,
Stefania Padula,
Dario Di Minno,
Francesco Caso,
Salvatore Iervolino,
Maria Vitiello,
Antonio Del Puente,
R. S. Panush
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Postprint:
archiving forbidden
Published version:
archiving forbidden
Data provided by 
Abstract
The rheumatic adverse effects accompanying treatment with aromatase inhibitors (AIs) in hormone-dependent breast cancer represent an area of clinical relevance and emerging concern. This report describes these rheumatic complaints detailing their clinical pattern.